[Pesticide trial by the phage induction method for potential mutagenic, carcinogenic, carcinostatic and teratogenic actions].
作者信息
Valerianov Ts, Popova A, Kuiumdzhiev A
出版信息
Acta Microbiol Bulg. 1979;4:69-74.
PMID:118646
Abstract
摘要
相似文献
1
2
Carcinogenic, mutagenic, teratogenic workshop.致癌、致突变、致畸研讨会。
Cancer Clin Trials. 1981;4 Suppl:37-41.
3
[Comparative study of three lysogenic systems for the testing of potential mutagens and carcinogens].[用于潜在诱变剂和致癌物检测的三种溶原性系统的比较研究]
Acta Microbiol Bulg. 1982;11:65-71.
4
Hygienic classification of pesticides in the Russian Federation.俄罗斯联邦农药的卫生分类
Regul Toxicol Pharmacol. 1998 Oct;28(2):79-84. doi: 10.1006/rtph.1998.1245.
5
A colorimetric assay of lysogenic induction designed for screening potential carcinogenic and carcinostatic agents.一种用于筛选潜在致癌剂和抗癌剂的溶原性诱导比色测定法。
Environ Mutagen. 1979;1(1):65-78. doi: 10.1002/em.2860010113.
6
Toxic effects of therapeutic agents: undesirable, teratogenic, mutagenic and carcinogenic effects.治疗药物的毒性作用：不良、致畸、致突变和致癌作用。
Dent Ther Newsl. 1984 May;1(4):15-6.
7
Microbiological models as screening tools for anticancer agents: potentials and limitations.微生物模型作为抗癌药物筛选工具：潜力与局限
Annu Rev Microbiol. 1982;36:415-33. doi: 10.1146/annurev.mi.36.100182.002215.
8
Comments on the carcinogenic, mutagenic, and teratogenic properties of anticancer drugs.关于抗癌药物致癌、致突变和致畸特性的评论。
Recent Results Cancer Res. 1980;74:306-11. doi: 10.1007/978-3-642-81488-4_37.
9
Cancer risks of medical treatment. Part I: Monitoring for drug safety and efficacy.医学治疗的癌症风险。第一部分：药物安全性和疗效监测。
Clin Bull. 1980;10(4):150-7.
10
Mutagenicity, carcinogenicity and teratogenicity of aluminium.铝的致突变性、致癌性和致畸性。
Mutat Res. 1988 Nov;196(3):247-57. doi: 10.1016/0165-1110(88)90009-7.
引用本文的文献
1
Teratological research using in vitro systems. V. Nonmammalian model systems.使用体外系统的致畸学研究。V. 非哺乳动物模型系统。
Environ Health Perspect. 1987 Jun;72:237-49. doi: 10.1289/ehp.8772237.
Zotero 插件